3
Total investments
3
Early stage
0
Mid stage
0
Late stage
2y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Member, Board of Advisors and Investor
2024
Blue Clay Health is a trailblazing healthcare technology company committed to revolutionizing care coordination for individuals with complex medical conditions. Our flagship platform, Ensemble, leverages cutting-edge technologies, including AI, machine learning, and wearable device integration, to connect patients with top specialists worldwide. By fostering seamless collaboration among multidisciplinary care teams and enabling personalized, data-driven treatment plans, we empower patients to access the highest quality care, regardless of their location.
Chris Riley, the founder of Blue Clay Health, is a graduate of both the U.S. Naval Academy and Harvard Business School, as well as a successful entrepreneur with a passion for healthcare innovation. Driven by his personal experience navigating the challenges of complex care after his 13-year-old son suffered a massive stroke, Chris designed Ensemble to address the gaps and inefficiencies he encountered in the healthcare system. Under his leadership, Blue Clay Health is poised to reshape the future of healthcare delivery and set a new standard for patient outcomes and experiences.
At Blue Clay Health, we believe that every patient deserves the opportunity to benefit from the collective wisdom of global medical experts and to receive care that is tailored to their unique needs. Through our unwavering commitment to patient-centric solutions and our relentless pursuit of technological excellence, we are paving the way for a new era of connected, compassionate, and highly effective healthcare. Our mission is to ensure that no family has to face the overwhelming challenges of complex care coordination alone, and to provide them with the tools, expertise, and support they need to achieve the best possible outcomes.
Investor and Board of Advisors
2024
At Rutabaga, we’re transforming the way businesses harness customer insights to drive strategic growth. Our AI-driven platform unifies fragmented customer data, turning it into actionable insights that align with your companys goals and accelerate product development.
What We Do:
Rutabaga’s cutting-edge technology consolidates qualitative data from various sources into a centralized knowledge graph. This advanced system enhances data visibility and ensures that every piece of customer feedback is accessible, relevant, and aligned with your strategic objectives. By leveraging our platform, product teams can make informed decisions faster, drive innovation, and consistently meet and exceed market demands.
Key Features:
:: Unified Insights: Consolidate and organize customer feedback across multiple channels, providing a comprehensive view of customer needs.
:: Strategic Alignment: Map insights directly to business goals, ensuring that every product decision supports your strategic direction.
:: Enhanced Efficiency: Automate workflows and reduce time spent on data analysis, allowing your team to focus on strategic tasks.
:: AI-Driven Analysis: Utilize advanced AI to extract meaningful insights and generate actionable strategies from your data.
Our Vision:
We believe in a world where customer insights are seamlessly integrated into the product development process, driving innovation and ensuring products truly meet market needs. With Rutabaga, businesses can unlock the full potential of their qualitative data, leading to better products, more satisfied customers, and a stronger competitive edge.
Join Us:
Stay ahead of the curve by leveraging Rutabagas innovative solutions. Follow us for updates, insights, and opportunities to be part of our journey in revolutionizing product development.
Board Member & Investor
2024
Pharma commercial teams are working from data thats already stale. By the time demand patterns show up in traditional analytics, the opportunity to act has passed.
SHAARPEC changes that. Our predictive analytics platform ingests and integrates real-world data across sources — claims, EHR, and beyond — structures it into longitudinal patient trajectories, and generates forward-looking demand signals. We identify where therapy adoption will emerge before it becomes visible in lagging data sources.
Built on five years of platform development, SHAARPEC enables brand, sales, and market access teams to see whats coming and allocate resources ahead of the curve.
Experience · 6 entries
All (6)
Investments (3)
Founder (2)
Board (1)
2025
Founder
2025
DeepHumiX develops AI-powered human digital twins and computational physiology platforms to model whole-body health, quantify resilience, predict trajectories, and enable longevity-focused healthcare.
By connecting fragmented innovations across human biology, DeepHumiX enables a new generation of integrated, scalable healthcare intelligence.
2024
Member, Board of Advisors and Investor
2024
Blue Clay Health is a trailblazing healthcare technology company committed to revolutionizing care coordination for individuals with complex medical conditions. Our flagship platform, Ensemble, leverages cutting-edge technologies, including AI, machine learning, and wearable device integration, to connect patients with top specialists worldwide. By fostering seamless collaboration among multidisciplinary care teams and enabling personalized, data-driven treatment plans, we empower patients to access the highest quality care, regardless of their location.
Chris Riley, the founder of Blue Clay Health, is a graduate of both the U.S. Naval Academy and Harvard Business School, as well as a successful entrepreneur with a passion for healthcare innovation. Driven by his personal experience navigating the challenges of complex care after his 13-year-old son suffered a massive stroke, Chris designed Ensemble to address the gaps and inefficiencies he encountered in the healthcare system. Under his leadership, Blue Clay Health is poised to reshape the future of healthcare delivery and set a new standard for patient outcomes and experiences.
At Blue Clay Health, we believe that every patient deserves the opportunity to benefit from the collective wisdom of global medical experts and to receive care that is tailored to their unique needs. Through our unwavering commitment to patient-centric solutions and our relentless pursuit of technological excellence, we are paving the way for a new era of connected, compassionate, and highly effective healthcare. Our mission is to ensure that no family has to face the overwhelming challenges of complex care coordination alone, and to provide them with the tools, expertise, and support they need to achieve the best possible outcomes.
CEO & Founder
2024
A network for entrepreneurs building in stealth.
Submit your information here so investors can find you:
harmonic.ai/get-discovered
Investor and Board of Advisors
2024
At Rutabaga, we’re transforming the way businesses harness customer insights to drive strategic growth. Our AI-driven platform unifies fragmented customer data, turning it into actionable insights that align with your companys goals and accelerate product development.
What We Do:
Rutabaga’s cutting-edge technology consolidates qualitative data from various sources into a centralized knowledge graph. This advanced system enhances data visibility and ensures that every piece of customer feedback is accessible, relevant, and aligned with your strategic objectives. By leveraging our platform, product teams can make informed decisions faster, drive innovation, and consistently meet and exceed market demands.
Key Features:
:: Unified Insights: Consolidate and organize customer feedback across multiple channels, providing a comprehensive view of customer needs.
:: Strategic Alignment: Map insights directly to business goals, ensuring that every product decision supports your strategic direction.
:: Enhanced Efficiency: Automate workflows and reduce time spent on data analysis, allowing your team to focus on strategic tasks.
:: AI-Driven Analysis: Utilize advanced AI to extract meaningful insights and generate actionable strategies from your data.
Our Vision:
We believe in a world where customer insights are seamlessly integrated into the product development process, driving innovation and ensuring products truly meet market needs. With Rutabaga, businesses can unlock the full potential of their qualitative data, leading to better products, more satisfied customers, and a stronger competitive edge.
Join Us:
Stay ahead of the curve by leveraging Rutabagas innovative solutions. Follow us for updates, insights, and opportunities to be part of our journey in revolutionizing product development.
Board Member & Investor
2024
Pharma commercial teams are working from data thats already stale. By the time demand patterns show up in traditional analytics, the opportunity to act has passed.
SHAARPEC changes that. Our predictive analytics platform ingests and integrates real-world data across sources — claims, EHR, and beyond — structures it into longitudinal patient trajectories, and generates forward-looking demand signals. We identify where therapy adoption will emerge before it becomes visible in lagging data sources.
Built on five years of platform development, SHAARPEC enables brand, sales, and market access teams to see whats coming and allocate resources ahead of the curve.
Show all 6 entries ↓
Similar investors
Analytics early-stage investors in United States
Investor lists
Lists that match Mei's portfolio
- Angel investors in the US6,019 investors
- Analytics early-stage investors in United States4,115 investors
- Health Care early-stage investors in United States5,007 investors
- Software early-stage investors in United States7,553 investors
- Early-stage startup investors in United States3,677 investors






